Interview with Zimbabwe’s Dr. Jackie Stone: COVID-19 Infection & Death Rates Plummet After Medicines Control Authority of Zimbabwe (MCAZ) Greenlight for Ivermectin Use
Posted on
TrialSite’s world survey of the various attempts to stave off and overcome COVID-19 brings the reader back to Zimbabwe, the location of an incredible, underreported scenario urging more attention. TrialSite first covered Zimbabwe when that nation’s medicines regulatory body decided to allow the use of ivermectin for research, and importantly, for research as a care option during the COVID-19 pandemic. This country experienced a relatively small wave of infections in August 2020 and then a far deadlier, steeper rise in December 2020 into the New Year. With some high profile members of the society (politicians, military leaders, etc.) infected, followed by some deaths, by January 27